Kythera Biopharmaceuticals, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Kythera Biopharmaceuticals, Inc. | KYTH - NASDAQ |
$14.00-$16.00 |
$16.00 |
$18.49 | 5.1 million | 10/11/2012 |
J.P. Morgan, Goldman Sachs & Co.
|
Co-Manager(s): Leerink Swann, Lazard Capital Markets |
Health Care |
Filing(s): Filed 2012-05-17
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Kythera Biopharmaceuticals, Inc., and our comprehensive analysis, click "Buy Market Research".
Kythera Biopharmaceuticals, Inc. Quote & Chart - Click for current quote -
KYTH
About Kythera Biopharmaceuticals, Inc. (adapted from Kythera Biopharmaceuticals, Inc. prospectus):
They are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel prescription products for the aesthetic medicine market.
This description is adapted from KYTHERA, Inc. prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as KYTHERA, Inc. "KYTH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved